YARAL Pharma Inc. is the US generic subsidiary of IBSA Pharma Inc. – a leading pharmaceutical company headquartered in Switzerland.
Our Parent Company
- Recognized as a world leader in the development of innovative technologies and products that improve the health and wellness of people.
- Known for its manufacturing expertise and decades-long track record of product quality and supply continuity.
- Continually building a wide-ranging portfolio of products across brands and generics in ten core therapeutic areas.
YARAL Pharma Company Pillars
YARAL Pharma is led by a team of experienced industry veterans and supported by the YARAL Pharma Board of Directors which is made up of members of IBSA’s leadership team.
Drawing on the strengths and capabilities of its parent company, YARAL Pharma’s leadership is committed to providing:
- High-quality products across a range of therapeutics areas
- Continuity of supply
- Exceptional levels of customer service
YARAL Pharma Leadership Team
YARAL Pharma Board of Directors
- President & CEO, IBSA Institut Biochimique SA – Arturo Licenziati
- CEO and Officer, IBSA Pharma Inc. – Nicholas Hart
- CEO, YARAL Pharma Inc. – Stephen Beckman
- CFO, IBSA Institut Biochimique SA – Luca Grassi
- Head of Legal Affairs, IBSA Institut Biochimique SA – Elisabetta Racca